Stocks were looking for direction on Wednesday, but this after the major indexes have all hit fresh all-time highs. The one trend that has dominated this bull market is that investors keep finding new reasons to buy stocks after every sell-off. Those same investors are looking for new investing and trading ideas to generate gains and income.
24/7 Wall St. reviews dozens of analyst research reports each day of the week to find new investing and trading ideas for our readers. Some of the top analyst reports cover stocks to buy. Other calls cover stocks to sell or to avoid.
Additional color and commentary has been added on some of these daily analyst calls. The consensus analyst price target data are from the Thomson Reuters sell-side research service.
These were the top analyst upgrades, downgrades and other research calls from Wednesday, September 20, 2017.
Biogen Inc. (NASDAQ: BIIB) was started with a Buy rating and assigned a $360 price target (versus a $317.93 prior close) at SunTrust Robinson Humphrey. Shares were indicated down 0.6% at $316.15 on Wednesday, and the consensus price target is $331.99. Biogen shares have traded in a range of $244.28 to $330.00 in the past 52 weeks.
Electronic Arts Inc. (NASDAQ: EA) was started with a Buy rating and assigned a $143 price target (versus a $120.21 close) at Buckingham Research. It has a 52-week range of $73.74 to $122.79 and a $125.59 consensus target price.
Gap Inc. (NYSE: GPS) was started as Overweight and assigned a $32 price target at Barclays. It has a 52-week range of $21.02 to $30.74 and a consensus target price of $26.16.
Intuit Inc. (NASDAQ: INTU) was started with a Buy rating and assigned a $165 price target (versus a $145.34 close) at Argus. The 52-week range is $103.22 to $146.04, and the consensus price target is $135.53.
Johnson & Johnson (NYSE: JNJ) was downgraded to Sell from Neutral with a $130 price target (versus a $135.22 close) at Goldman Sachs. Shares were indicated down 1.7% at $133.00 on Wednesday, in a 52-week range of $109.32 to $137.08. The consensus target price is $136.89.
3M Co. (NYSE: MMM) was downgraded to Underweight from Neutral at JPMorgan, but the firm raised its price target to $201 from $185. The recent rally is said to ignore channel disruptions and risks stemming from declines in auto, China and electronics. 3M was indicated to open down 1.2% at $211.00 on Wednesday, and it has a 52-week range of $163.85 to $214.65 and a consensus target price of $205.45.
Follow @Jonogg on Twitter to receive the daily analyst calls and other market research calls directly on your feed.
Other key analyst upgrades, downgrades and initiations were seen in the following: